Dr Rabasa-Lhoret at Tout le monde en parle

Dr Rabasa-Lhoret at Tout le monde en parle

Prevention, treatment, communication, at the heart of the mission of the IRCM clinic

In the wake of the appearance of its Director of the Metabolic Diseases Research Unit and the Diabetes Clinic, Dr. Rémi Rabasa-Lhoret, on the show Tout le monde en parle, the IRCM underlines the importance of informing the public about the benefits as well as health risks surrounding taking medications such as Ozempic. The documentary La piqure de la minceur, on the appetite suppressant phenomenon, to be broadcast on the specialty channel Crave on April 18 and Canal Vie on August 21 and in which Dr Rabasa-Lhoret takes part, addresses the important questions surrounding the trend leading many people to resort to such medications for weight loss purpose when it’s initially intended for people living with diabetes.. 

“We must stop stigmatizing overweight people, obesity is a disease which has a major genetic component. However, at the same time, obesity increases the risk for several diseases. Not everyone needs to lose weight, but for some patients, losing weight improves health. If these people have good lifestyle support, there may be a place for prescribing medications." 

Dr. Rémi Rabasa-Lhoret is also an endocrinologist at the CHUM (the IRCM clinic is affiliated with the CHUM), president of the professional council of Diabète Québec, and full professor in the Department of Nutrition at the Faculty of Medicine, Université de Montréal

Early detection, a proven approach
The IRCM highlights the importance of early detection and regular monitoring for metabolic diseases. Early diagnosis of diabetes is essential for the implementation of treatment. For type 2, the most common form of diabetes, the first steps in management include diet and exercise to delay the need for medication and reduce the risk of developing complications related to this disease. For type 1 diabetes, early diagnosis helps avoid hospitalization. Finally, for rarer forms of diabetes such as that secondary to cystic fibrosis, early diagnosis also contributes to lung health.

About the IRCM Diabetes Clinic
The IRCM Diabetes Clinic assesses and supports people living with type 1 and type 2 diabetes, as well as diabetes secondary to cystic fibrosis. It offers specialized multidisciplinary care and carries out teaching tasks for patients and healthcare professionals, as well as conducting research projects. These three objectives are aimed at reducing the adverse consequences of diabetes for those affected. 

The IRCM would like to acknowledge the support of the Ministère de l’Économie, de l’Innovation et de l’Énergie, the Ministère de la Santé et des services sociaux, as well as the unfailing support of the IRCM Foundation.

Trailer of the documentary La piqure de la minceur :

Back to news list


events and more


IRCM Foundation

Be part of the

Support health research